,D,,300,6%,7% ,,,,, ,,,,, ,75%,, ,,, ,,,, ,D, , ,,,, ,D D,30~1;D,, , ,,D, 22%,1814,6, (2022,120~200,25~35,300~500,,,,,, ,, , K ,K K ,,, ,,6000 ,D, ,,16%~20% ,, ,,5,,,7 ,,,
01 4 4 0~13~437%30% 12 02 73%35 6.37.6507.6~10.7 03 12 15075300150 6~8
T10T11FDGSUV12.8SUV11.4 3AFDG FDG1.7cm CD1aCD207S-100 Langerhans cell histiocytosisLCHXLCHHand-Schuller-ChristianLCHLetterer-SiweLCH370%Birbeck LCH11514211-2/ 50%PET/CT LCH 1 2 3 T1WIT1WI… [+163 chars]
01 4 4 0~13~437%30% 12 02 73%35 6.37.6507.6~10.7 03 12 15075300150 6~8
20201848National Institutes of HealthHealth Data Research UK Paul Elliott24 46CNatureNature Food Joram Posma National Institute for Health ResearchMedical Research Council 5 John Mathers B12Co… [+22 chars]
6 B2B2 01 B B B12.B1.B2.B3.B5.B6.B7.B9.B12 BB B 1. B... 2. B.. 3. B 02 B2 1. B2B2 2. B2..B2. 3. b2b2. . 03 B2 1. b2 b2.b2 2. B2.B2 3. B2B6B6 B2 B2 4. B2BB2B2 CT.CT… [+79 chars]
37.2 DNADNA PET 1. 55 2. 1 2 3 4 5 3. 1. TNM Ttumor Nlymph node Mmetastasis TNM 2. 3. 200ABHER-2 1. 22%(lARC)700025069 2. 57248 3. (lARC)2014IARC2003I 4. 1. 2. … [+72 chars]
,D,,300,6%,7% ,,,,, ,,,,, ,75%,, ,,, ,,,, ,D, , ,,,, ,D D,30~1;D,, , ,,D, 22%,1814,6, (2022,120~200,25~35,300~500,,,,,, ,, , K ,K K ,,, ,,6000 ,D, ,,16%~20% ,, ,,5,,,7 ,,,
Xantha Leatham 2022 8 14 17:22 | 2022 8 14 17:22 NHS Digital 20%2021/22 234,000 Covid NHS NHS
1911·Joh. Ohm | cancer.gov 1945B. Rycroft endophthalmitis | 70 VEGFVEGFVEGF AMDVEGF | DOI:10.2147/IJN.S30725 5% 100% 6 Advanced Healthcare Materials Terasaki Institute microneedle P… [+102 chars]
T10T11FDGSUV12.8SUV11.4 3AFDG FDG1.7cm CD1aCD207S-100 Langerhans cell histiocytosisLCHXLCHHand-Schuller-ChristianLCHLetterer-SiweLCH370%Birbeck LCH11514211-2/ 50%PET/CT LCH 1 2 3 T1WIT1WI… [+163 chars]
·Robert Southey Goldilock ...... 102Pa 104Pa 109Pa - 0.45GPa 20GPa Nature Materials 2Pa/m 400Pa200Pa 1~2 Pa/m 3T3 fibroblasts MDA-MB-231Durotaxis Directed cell migration towards softer en… [+476 chars]
